Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Lindis Biotech GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT04819399
- Locations
- 🇩🇪
Urologie Planegg, München, Germany
© Copyright 2024. All Rights Reserved by MedPath